Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Mitochondrial ribosomal protein L50 pseudogene 2 (MRPL50P2) is a processed pseudogene sequence found on human chromosome 2q34 and is derived from the mitochondrial ribosomal protein L50 gene family[2][4][8][9]. It does not encode a functional protein and shows sequence similarity with its parent gene but lacks biological activity or relevance as a therapeutic target. Pseudogenes like MRPL50P2 serve as genomic records of evolutionary events and may sometimes have roles in gene regulation or serve as molecular sponges for non-coding RNAs, though no such function has been reported for MRPL50P2 specifically[2][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mitochondrial ribosomal protein L50 pseudogene 2 (MRPL50P2).